BETA
Beta Drugs Ltd.
Pharmaceuticals & Drugs
Setup readiness
Early Trend
- Pivot Levels
- ₹1869.2-2261.2
- Support Level
- ₹1987.7
- Resistance
- ₹2700.0
- Risk Distance
- 12.1% to stop
Reference levels for educational study only. Not a recommendation to buy or sell.
Swing Edge Intelligence
Structured setup analysis · research only
Setup status · Moderate technical setup
Setup shows several positive technical characteristics along with areas to monitor.
Bullish factors
- Failure flags: Overextended, Weak breakout close, RSI exhaustion (96th pct, +7.6%/5d).
- Extended 42%/10d — climax risk.
- Gain 10d: 42.0% / 20d: 45.4%.
- Overextended 41% above MA50 (chase risk, score −2).
- RSI 74 (96th pct 1y, ATR vol 83th pct).
- Stage2: 6/8.
Risk factors
- Stop distance is wide (12%)
- 4 distribution days observed recently
- RSI at 74 (elevated level)
Overall view
Moderate technical setup — momentum and institutional cues show broad alignment.
Setup research
BETA — trend, RS & risk snapshot (not a trade recommendation)
Signal · context · invalidation · risk · skip reasons — research only
Positives
Price is clearing the pivot
- RS line near highs
- Stage 2 uptrend structure detected
Context & regime
- Market regime Mixed / range-bound
- Trend stage Stage 2 — tradable
- Sector Mid-pack (#23/46)
- Relative strength Leader (RS 96)
- Trend strength Strong (ADX 42)
Negatives
This idea is wrong below ₹1987.7 (5.2% away)
Base / stop support breaks — the swing thesis is wrong below here
- Stop / base low₹1987.7
- Pivot — failure re-entry below₹2250.0
Risk distance
Risk ≈ ₹273.6/share from entry ₹2261.2.
Stop is wide (12%) for a swing — sizing will be small
Reasons to skip 4
Disqualifiers that apply even if the score looks good.
- Stop distance is wide (12%)
- 4 distribution days observed recently
- RSI at 74 (elevated level)
- High failure risk score (84/100)
Setup metrics Momentum Continuation
BETA Technical Analysis & Swing Setup
Grouped structure, momentum and risk from the latest momentum continuation scan.
Volume Profile bullish
- POC
- ₹1402.76
- VAH
- ₹1878.61
- VAL
- ₹1170.64
- Vol above POC
- 66.4%
Institutional Activity · Neutral
- Avg cost basis
- ₹1521.15
- Acc zone
- ₹1055.1–1771.2
- Accumulation sessions
- 5
- CMF
- -0.01
Structure
Momentum
Risk
More scanner fields
BETA Support & Resistance Levels
Research chart
Daily price action with pivot, support, and resistance levels from our latest scan, plus relative strength vs Nifty.
Pivot levels, support and resistance are drawn on the price chart. · Research only.
Sector RS rank · latest scan
Loading peer comparison…
Seasonality — monthly returns
How this stock moved month by month over the last ~2 years.
A rough tendency, not a reliable pattern. Research only, not advice.
AI insights
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Pattern context 52w · setup · flow
52-week range
—Stage-2 ideal band · Early recovery
Pattern highlights
Pattern signals from the latest scan
Smart money flow
Last 60 sessions · accumulation vs distribution
Setup intelligence Overhead · VCP · radar · risk
Overhead supply
Resistance ceiling above current price
Chase / failure risk
Honest read on exhaustion & extended moves
Base / VCP coil
Depth, contractions & pivot distance
Setup quality radar
Shape of the setup in one view
Peer comparison Sector peers
Sector Peer Comparison
Loading sector peers…
BETA FAQ Common swing-trading questions
Frequently asked questions about BETA
What are the screener observations for BETA?
On Swing Edge's swing-setup framework, Beta Drugs Ltd. (BETA) currently grades B — workable setup. Price is clearing the pivot. Flagged yesterday. This is educational research, not investment advice.
What are BETA's support and resistance levels?
For BETA, near-term support sits around ₹1,987.7 (the base/stop zone); overhead resistance is around ₹2,250.0 (the breakout pivot); the next resistance above is ₹2,700.0. This is educational research, not investment advice.
What is the breakout / pivot level for BETA?
The breakout pivot for BETA is around ₹2,250.0. Price is about 6.8% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.
Is BETA above its 50-day and 200-day moving averages?
Yes — BETA is in a confirmed Stage 2 uptrend, trading above its rising 50- and 200-day moving averages, the zone where swing setups tend to work best. This is educational research, not investment advice.
How strong is BETA versus the market (RS rank)?
BETA has a relative strength (RS) rank of 96 out of 100 versus the NSE universe, making it a market leader — stronger than most NSE stocks. Trend strength (ADX) reads 42, indicating a strong trend. This is educational research, not investment advice.
Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.
Prices and day-change figures use the last daily close from scan data dated 2026-06-28 — not live intraday NSE quotes.